Medica Sur SA de CV

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: MXP510121215
MXN
62.00
1 (1.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate 3.90% of over the last 5 years

 
2

Flat results in Dec 25

3

With ROE of 21.71%, it has a fair valuation with a 2.39 Price to Book Value

4

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

MXN 6,260 Million (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.02%

stock-summary
Debt Equity

-0.22

stock-summary
Return on Equity

20.95%

stock-summary
Price to Book

2.44

Revenue and Profits:
Net Sales:
1,180 Million
(Quarterly Results - Sep 2025)
Net Profit:
124 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.73%
0%
12.73%
6 Months
47.62%
0%
47.62%
1 Year
77.65%
0%
77.65%
2 Years
48.33%
0%
48.33%
3 Years
61.46%
0%
61.46%
4 Years
16.98%
0%
16.98%
5 Years
84.96%
0%
84.96%

Medica Sur SA de CV for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
3.70%
EBIT Growth (5y)
3.90%
EBIT to Interest (avg)
8.23
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
1.33
Tax Ratio
29.58%
Dividend Payout Ratio
28.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.99%
ROE (avg)
16.72%

Valuation key factors

Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
2.39
EV to EBIT
7.74
EV to EBITDA
6.04
EV to Capital Employed
2.61
EV to Sales
1.20
PEG Ratio
0.58
Dividend Yield
0.02%
ROCE (Latest)
33.76%
ROE (Latest)
21.71%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -0.11% vs -1.96% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -9.12% vs -4.50% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,180.00",
          "val2": "1,181.30",
          "chgp": "-0.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "228.90",
          "val2": "247.90",
          "chgp": "-7.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "41.00",
          "val2": "19.10",
          "chgp": "114.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "123.50",
          "val2": "135.90",
          "chgp": "-9.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "153.20%",
          "val2": "166.70%",
          "chgp": "-1.35%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.61% vs 6.77% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -24.27% vs 18.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,402.80",
          "val2": "4,129.80",
          "chgp": "6.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "882.30",
          "val2": "844.60",
          "chgp": "4.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "123.80",
          "val2": "119.60",
          "chgp": "3.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-74.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "422.50",
          "val2": "557.90",
          "chgp": "-24.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "156.30%",
          "val2": "161.30%",
          "chgp": "-0.50%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
1,180.00
1,181.30
-0.11%
Operating Profit (PBDIT) excl Other Income
228.90
247.90
-7.66%
Interest
41.00
19.10
114.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
123.50
135.90
-9.12%
Operating Profit Margin (Excl OI)
153.20%
166.70%
-1.35%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is -0.11% vs -1.96% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -9.12% vs -4.50% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
4,402.80
4,129.80
6.61%
Operating Profit (PBDIT) excl Other Income
882.30
844.60
4.46%
Interest
123.80
119.60
3.51%
Exceptional Items
-74.40
0.00
Consolidate Net Profit
422.50
557.90
-24.27%
Operating Profit Margin (Excl OI)
156.30%
161.30%
-0.50%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 6.61% vs 6.77% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -24.27% vs 18.00% in Dec 2023

stock-summaryCompany CV
About Medica Sur SA de CV stock-summary
stock-summary
Medica Sur SA de CV
Pharmaceuticals & Biotechnology
Medica Sur SAB de CV is a Mexico-based company primarily engaged in the healthcare sector. The Company manages hospitals, emergency and diagnostic centers, medical laboratories, organ and blood banks, as well as an accommodation place. It provides medical services within various specializations, such as anatomic pathology, cardiology, gynecology and obstetrics, neonatology, neurophysiology, odontology, oncology, ophthalmology, orthopedics, otolaryngology, pediatrics, radiology and imaging, as well as radiosurgery. In addition, the Company offers medical tourism services and distributes drugs. It forms a part of Mayo Clinic Care Network. The Company operates through a range of subsidiaries, such as Corporacion de Atencion Medica SA de CV, El Portal Medico SA de CV, Servicios de Administracion Hospitalaria SA de CV and Telemed SA de CV. The Company is owned by Neuco SA de CV.
Company Coordinates stock-summary
Company Details
Puente de Piedra 150, Col. Toriello Guerra TLALPAN None : 14050
stock-summary
Tel: 52 55 5424720052 5 4247200
stock-summary
Registrar Details